Amalgamated Bank Veracyte, Inc. Transaction History

Amalgamated Bank

$12.2 Billion
Q4 2024

A detailed history of Amalgamated Bank transactions in Veracyte, Inc. stock. As of the latest transaction made, Amalgamated Bank holds 2,556 shares of VCYT stock, worth $115,173. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,556

Previous 2,556 -0.0%

Holding current value

$115,173

Previous $87,000 16.09%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$18.86 - $23.55 $1,961 - $2,449	104 Added 4.24%	2,556 $55,000
Q1 2024 Apr 23, 2024	SELL	$21.0 - $29.1 $81,816 - $113,373	-3,896 Reduced 61.37%	2,452 $54,000
Q4 2023 Feb 06, 2024	SELL	$19.72 - $28.68 $14,395 - $20,936	-730 Reduced 10.31%	6,348 $175,000
Q2 2023 Aug 11, 2023	SELL	$20.96 - $26.99 $10,396 - $13,387	-496 Reduced 6.55%	7,078 $180,000
Q1 2023 May 02, 2023	SELL	$20.58 - $27.89 $35,973 - $48,751	-1,748 Reduced 18.75%	7,574 $169,000
Q4 2022 Feb 10, 2023	BUY	$15.31 - $29.94 $1,959 - $3,832	128 Added 1.39%	9,322 $221,000
Q3 2022 Nov 09, 2022	BUY	$16.58 - $27.9 $1,475 - $2,483	89 Added 0.98%	9,194 $153,000
Q2 2022 Aug 15, 2022	BUY	$15.45 - $29.52 $14,909 - $28,486	965 Added 11.86%	9,105 $181,000
Q1 2022 Jun 30, 2022	SELL	$21.94 - $42.51 $13,295 - $25,761	-606 Reduced 6.93%	8,140 $224,000
Q4 2021 Feb 15, 2022	SELL	$36.09 - $53.79 $2,815 - $4,195	-78 Reduced 0.88%	8,746 $360,000
Q3 2021 Oct 29, 2021	SELL	$35.62 - $52.97 $23,259 - $34,589	-653 Reduced 6.89%	8,824 $410,000
Q2 2021 Aug 16, 2021	BUY	$32.94 - $56.62 $1,383 - $2,378	42 Added 0.45%	9,477 $379,000
Q1 2021 May 13, 2021	BUY	$44.47 - $81.38 $21,479 - $39,306	483 Added 5.4%	9,435 $507,000
Q4 2020 Feb 12, 2021	BUY	$32.49 - $61.88 $1,462 - $2,784	45 Added 0.51%	8,952 $438,000
Q3 2020 Oct 30, 2020	BUY	$26.73 - $35.67 $24,297 - $32,424	909 Added 11.37%	8,907 $289,000
Q2 2020 Aug 10, 2020	SELL	$19.49 - $28.11 $9,803 - $14,139	-503 Reduced 5.92%	7,998 $207,000
Q1 2020 May 13, 2020	SELL	$16.13 - $30.17 $6,871 - $12,852	-426 Reduced 4.77%	8,501 $207,000
Q4 2019 Feb 13, 2020	BUY	$20.78 - $29.99 $185,503 - $267,720	8,927 New	8,927 $249,000
Q3 2019 Nov 13, 2019	SELL	$23.87 - $30.93 $199,505 - $258,512	-8,358 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$22.1 - $28.56 $184,711 - $238,704	8,358 New	8,358 $238,000

Others Institutions Holding VCYT

# of Institutions

316

Shares Held

81.8M

Call Options Held

134K

Put Options Held

13.3K

View Full List

About VERACYTE, INC.

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $3.23B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

More about VCYT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Account

Amalgamated Bank Veracyte, Inc. Transaction History